Idiopathic neuropathy: new paradigms, new promise

Journal of the Peripheral Nervous System - Tập 17 Số s2 - Trang 43-49 - 2012
Mike A. Singer1, Steven Vernino2, Gil I. Wolfe3
1University of Texas Southwestern Medical Center
2Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA
3Women and Children's Hospital of Buffalo

Tóm tắt

Idiopathic neuropathy, now designated as chronic idiopathic axonal polyneuropathy (CIAP), is a major public health problem in the United States. The disorder affects an estimated 5–8 million Americans, comprising about one‐third of patients with neuropathy, based on data from referral centers. Typically, patients develop symptoms in the sixth decade or older. The onset is insidious, with numbness, paresthesias, and pain appearing over months to years. Although strength is generally preserved, the sensory loss and pain can be disabling. The clinical approach to this condition has evolved in important ways over the years, enabling improved diagnosis and characterization of this population. Current work has focused on identifying modifiable risk factors that may be associated with idiopathic neuropathy. The results may suggest that an underlying mechanism such as oxidative stress contributes to the development of CIAP.

Từ khóa


Tài liệu tham khảo

10.1007/s00415-003-0168-3

10.1212/WNL.0b013e3182166ebe

Corvisier N, 1987, Les neuropathies de cause indéterminée., Rev Neurol (Paris), 143, 279

10.1136/jnnp.2006.091074

10.1093/brain/awn093

10.1002/ana.410100304

10.1002/mus.20846

10.1111/j.1600-0404.1983.tb04560.x

10.1001/archneur.1982.00510160040007

10.1172/JCI21625

10.1111/j.1600-0404.1995.tb00150.x

Gowers WR, 1886, A manual of diseases of the nervous system

Herskovitz S, 2010, Contemporary Neurology Series: Peripheral Neuropathies in Clinical Practice.

Höke A, Neuroprotection in the peripheral nervous system: rationale for more effective therapies (2006)., Arch Neurol, 63, 1681, 10.1001/archneur.63.12.1681

10.1093/brain/awh192

10.1093/brain/108.4.897

10.1002/mus.1132

10.1001/archneur.63.8.1055

10.1055/s-2008-1069265

10.1016/S0022-5193(03)00304-7

10.1016/j.amjhyper.2004.02.004

10.1016/j.pcad.2008.08.003

10.1111/j.1085-9489.2005.10106.x

Matthews WB, 1952, Cryptogenic polyneuritis., Proc R Soc Med, 45, 667

10.1055/s-2008-1062270

10.1136/jnnp.47.5.530

10.2337/dc07-0817

10.1136/jnnp.56.10.1066

10.1002/mus.1137

10.1212/WNL.53.8.1641

10.1089/met.2005.3.113

10.1111/j.1600-0404.1970.tb07459.x

10.1002/mus.1124

Rose FC, 1960, Peripheral neuropathy., Proc R Soc Med, 53, 51

10.1007/s00415-004-0499-8

10.2337/diacare.24.8.1448

Smith AG, (2006). Idiopathic neuropathy, prediabetes and the metabolic syndrome., J Neurol Sci, 242, 9, 10.1016/j.jns.2005.11.020

10.2337/dc06-0224

10.1586/14779072.3.6.1061

10.1136/jnnp.29.3.205

10.1136/jnnp.72.5.590

Traub R, 2010, MedLink Neurology.

10.1001/archneurpsyc.1934.02250080123007

10.1210/er.2003-0019

10.1007/s00415-005-0064-0

10.1002/mus.20057

10.1001/archneur.56.5.540

10.1097/CND.0b013e3182196e3c

Thông tin
Thông tin xuất bản

Journal of the Peripheral Nervous System

Tập 17 Số s2

43-49

Thông tin tác giả